Bristol Myers Reports Late-Stage Trial Wins for Two Drugs
Bristol Myers said its pipeline candidate RYZ101 significantly improved in a late-stage trial; the report also cites a trial win for a lung-disease drug.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.